High Vascular Count and VEGF Overexpression Linked to Poor Prognosis in Small Cell Lung Cancer
Author Information
Author(s): Fontanini G, Faviana P, Lucchi M, Boldrini L, Mussi A, Camacci T, Mariani M A, Angeletti C A, Basolo F, Pingitore R
Primary Institution: University of Pisa
Hypothesis
Can neo-angiogenesis and vascular endothelial growth factor (VEGF) serve as indicators of clinical outcomes in small cell lung carcinoma?
Conclusion
Higher vascular counts and VEGF expression are associated with shorter overall and disease-free survival in patients with small cell lung carcinoma.
Supporting Evidence
- Patients with high vascular counts showed significantly shorter overall and disease-free survival.
- VEGF expression was found to be an independent prognostic factor for overall survival.
- The study included a comprehensive analysis of clinico-pathological parameters.
Takeaway
This study found that patients with more blood vessels and higher levels of a specific protein (VEGF) in their lung tumors tend to have worse outcomes.
Methodology
The study analyzed 75 patients with small cell lung carcinoma who underwent surgery, assessing vascular count and VEGF expression through immunohistochemistry.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the specific patient selection criteria.
Limitations
The study is retrospective and based on a limited sample size from a specific time period.
Participant Demographics
The cohort consisted of 72 males and 3 females, with a mean age of 61.7 years.
Statistical Information
P-Value
P=0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website